BioHorizons has near 10% of the global implant market and it will now be reecommending Remplir with them. That's huge product demand.
A little exert from BioHorizons:
"AlloDerm™ RTM is the most widely accepted and researched acellular dermal matrix for dental soft tissue applications. Grafton DBM is a proven bone graft material with clinical success in multiple forms. In 2004, MinerOss®, a mixture of allograft mineralized cortical and cancellous chips, was added to address a wide range of dental bone grafting applications."
They are now selling Remplir instead of Grafton DBM presumably.
Like Paul, I am excited.
Good job you stayed in on half your holdings Hotdog (very nice day on IMU too!)
- Forums
- ASX - By Stock
- Ann: OCC Signs Striate Global License And Manufacturing Agreement
BioHorizons has near 10% of the global implant market and it...
-
- There are more pages in this discussion • 238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.54M |
Open | High | Low | Value | Volume |
37.0¢ | 37.3¢ | 37.0¢ | $8.069K | 21.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32843 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 35726 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32843 | 0.365 |
8 | 119640 | 0.360 |
5 | 73319 | 0.355 |
6 | 107025 | 0.350 |
2 | 31886 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 35726 | 1 |
0.375 | 10567 | 3 |
0.380 | 10671 | 1 |
0.390 | 79373 | 6 |
0.395 | 30226 | 2 |
Last trade - 12.41pm 28/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online